Latest News From Pharmachem
-
Baxalta Inc signs deal to develop drugs for rare cancers
05 January, 2016
Drugmaker Baxalta Inc has signed a deal with privately held Symphogen under which the companies will develop immuno-oncology drugs to treat rare cancers.
-
Irish Medtech Firm to raise €15 million to develop bone repair technology
07 January, 2016
SurgaColl Technologies, a fledgling Irish medtech company is looking to raise €15 million to develop and commercialise revolutionary technology that will allow doctors to repair bone and cartilage in patients.
-
Dublin based Venn Life Sciences signs contracts worth over €3.4m
12 January, 2016
The AIM-listed Irish company provides clinical trial management to pharmaceutical, biotech and medical device companies.
-
New Pharmaceutical centre of excellence established in Cork
13 January, 2016
Scientific consumer research firm, SRL Research, has teamed up with UCC’s School of Pharmacy and the Clinical Research Facility Cork (CRF-C) at Mercy University Hospital to establish a dedicated centre of excellence - SRL PHARMA
-
Irish Medical Technology Company 3D4Medical announces 70 new jobs
15 January, 2016
The company will create positions in the highly skilled technical, design and medical sectors including: software developers, 3D graphic artists and medical writers and experts, to build on the success of its world-renowned applications.